Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1996 | 09-1996 | 06-1996 | 03-1996 | 12-1995 | |
| Sales | 6,500 | 5,553 | 5,028 | 5,548 | 5,377 |
| Gross Profit | 6,500 | 5,553 | 5,028 | 5,548 | 5,378 |
| Operating Expenses | 0 | 9,858 | 8,506 | 0 | 7,138 |
| Operating Income | 6,500 | -4,305 | -3,478 | 5,548 | -1,761 |
| Other Income | 0 | 0 | 0 | 0 | 1 |
| Pre-tax Income | 6,500 | -4,305 | -3,478 | 5,548 | -1,760 |
| Net Income Continuous | -1,810 | -4,305 | -3,478 | -2,200 | -1,761 |
| Net Income | $-1,810 | $-4,305 | $-3,478 | $-2,200 | $-1,761 |
| EPS Basic Total Ops | -0.03 | -0.07 | -0.06 | -0.04 | -0.03 |
| EPS Basic Continuous Ops | -0.03 | -0.07 | -0.06 | -0.04 | -0.03 |
| EPS Diluted Total Ops | -0.03 | -0.07 | -0.06 | -0.04 | -0.03 |
| EPS Diluted Continuous Ops | -0.03 | -0.07 | -0.06 | -0.04 | -0.03 |
| EBITDA(a) | $7,343 | $-3,475 | $-3,478 | $5,548 | $-1,761 |